ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea flag South Korea · Delayed Price · Currency is KRW
585.00
+5.00 (0.86%)
At close: Jul 31, 2026

KOSDAQ:034940 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-4,727-6,806-9,605-10,514560.69-8,044
Depreciation & Amortization
2,4132,4322,3892,3872,3882,893
Loss (Gain) From Sale of Assets
-2,547-1,544-293.83-85.73--8.72
Asset Writedown & Restructuring Costs
1,1291,129246.281,989107.11,938
Loss (Gain) From Sale of Investments
-484.89-450.842.95-171.99-235.85-1,605
Loss (Gain) on Equity Investments
0.93-7.09-14.78-19.874.83-17.96
Provision & Write-off of Bad Debts
-189.11-90.71504.79202.2-230.01269.87
Other Operating Activities
3,7403,9332,6664,3841,8643,899
Change in Accounts Receivable
290.33450.31,5432,287-2,644400.47
Change in Inventory
945.7700.84596.73-2,212-549.252,292
Change in Accounts Payable
-262.04-1,373-646.98507.621,30481.5
Change in Other Net Operating Assets
-3,828-2,553-1,856-228.1-4,012-3,580
Operating Cash Flow
-3,518-4,180-4,468-1,475-1,443-1,480
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2,024-1,986-551.31-831.13-2,782-3,544
Sale of Property, Plant & Equipment
5,0712,612481.47128.61-14.55
Sale (Purchase) of Intangibles
-12.99-36.41-229.11-111.52-140.19-319.99
Investment in Securities
1,5463,151-1,1591,9441,4791,566
Other Investing Activities
78.87189.62-343.71-398.94-110.22417.53
Investing Cash Flow
4,6583,931-1,802731.38-1,553-1,866

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-30,1669,63015,3497,6589,344
Long-Term Debt Repaid
--28,910-3,406-17,012-5,863-4,621
Net Debt Issued (Repaid)
1,3991,2566,224-1,6621,7954,723
Other Financing Activities
-698-734-32-27.2211.51101.29
Financing Cash Flow
700.61521.636,192-1,6901,8074,825

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.69-45.09127.94-44.95-33.84106.45
Net Cash Flow
1,842227.5950.04-2,478-1,2231,585

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-5,542-6,165-5,019-2,306-4,225-5,024
Free Cash Flow Growth
------
Free Cash Flow Margin
-9.30%-10.39%-8.01%-3.66%-6.13%-8.73%
Free Cash Flow Per Share
-179.07-199.01-162.01-74.45-136.37-162.17
Levered Free Cash Flow
-4,925-5,338-894.16-850.27-3,337-3,096
Unlevered Free Cash Flow
-4,162-4,594-197.11-238.19-2,914-2,861

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,0881,0711,026913.95564.55287.07
Cash Income Tax Paid
1.69-3.2714.42-10.98-45.22-
Change in Working Capital
-2,854-2,775-363.43354.91-5,902-805.67